Pfizer Sees Celebrex Script Growth After Bextra Withdrawal

Script data indicates patients are switching from Bextra to Celebrex, Pfizer says. In the last three weeks, Celebrex has led the NSAID market in new prescription growth.

More from Archive

More from Pink Sheet